VCNX
VACCINEX INC
stockOTC
located in rochester, ny, vaccinex is a privately held, clinical-stage biotechnology company engaged in the discovery and development of human therapeutic monoclonal antibodies, therapeutic vaccines and other biologic products to treat serious diseases with unmet needs, including cancer, multiple sclerosis, and other autoimmune diseases. we conduct discovery research in-house and in collaboration with world-class academic institutions and biotechnology companies, and have an experienced in-house drug development management team to advance our pre-clinical and clinical stage biopharmaceutical development programs. our development team is led by seasoned industry veterans with both operational and executive level biopharmaceutical industry experience in therapeutic biologics research, manufacturing, quality assurance, quality control, toxicology, pharmacology, drug regulatory affairs, and clinical affairs. we are committed to innovation in the way we approach drug discovery and develop
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.04 | 2026-09-28 | -2.88% | -0.038 |
| 1M | 0.75 | 2026-09-03 | +34.67% | -4.539 |
| 3M | 1.12 | 2026-07-06 | -9.65% | 2.832 |
| 6M | 0.93 | 2026-04-06 | +8.60% | -0.319 |
| 1Y | 0.64 | 2025-10-02 | +57.81% | 1.026 |
| 2Y | 2.55 | 2024-10-04 | -60.39% | — |
| 5Y | 436.80 | 2021-10-04 | -99.77% | 0.100 |
VACCINEX INC (OTC:VCNX) stock price today is $1.01, and today's volume is 117. VCNX is down 1.463% today. The 30 day average volume is 2,212. VCNX market cap is $2.70M with 2.68M shares outstanding.